Alvotech Market Capitalization from 2010 to 2025

ALVO Stock  USD 11.82  0.05  0.42%   
Alvotech Market Cap yearly trend continues to be very stable with very little volatility. Market Cap is likely to drop to about 2.9 B.
Check Alvotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alvotech's main balance sheet or income statement drivers, such as Interest Income of 5.8 M, Depreciation And Amortization of 20.4 M or Interest Expense of 139.4 M, as well as many indicators such as Price To Sales Ratio of 33.56, Dividend Yield of 0.0 or Days Sales Outstanding of 282. Alvotech financial statements analysis is a perfect complement when working with Alvotech Valuation or Volatility modules.
  
Check out the analysis of Alvotech Correlation against competitors.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.

Latest Alvotech's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Alvotech over the last few years. It is Alvotech's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alvotech's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.57 B10 Years Trend
Pretty Stable
   Market Cap   
       Timeline  

Alvotech Market Capitalization Regression Statistics

Arithmetic Mean2,727,167,175
Geometric Mean2,725,237,509
Coefficient Of Variation3.94
Mean Deviation60,042,972
Median2,726,437,961
Standard Deviation107,542,173
Sample Variance11565.3T
Range391.3M
R-Value0.19
Mean Square Error11944.1T
R-Squared0.04
Significance0.48
Slope4,291,693
Total Sum of Squares173479.8T

Alvotech Market Capitalization History

20252.9 B
2024B
20202.6 B

About Alvotech Financial Statements

Alvotech investors utilize fundamental indicators, such as Market Capitalization, to predict how Alvotech Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. The company was founded in 2013 and is headquartered in Reykjavik, Iceland. Alvotech is traded on NASDAQ Exchange in the United States.
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out the analysis of Alvotech Correlation against competitors.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.85)
Revenue Per Share
1.557
Quarterly Revenue Growth
4.786
Return On Assets
(0.01)
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.